Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2012, Vol. 32 Issue (6): 74-78    DOI:
TECHNIQUES AND METHODS     
Location of EGFP Tag Affects the Binding Activity of Peptide Fusions
WANG Hai, SHI Bi-zhi, YANG Sheng-li, LI Zong-hai, LUO Xiao-ying
State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai Cancer Institute, Shanghai 200032, China
Download: HTML   PDF(733KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  Purpose: To investigate whether the location between targeting peptide and tag protein (eGFP) would influence the binding capacity of fusing protein to cell. Methods: To get Ge11 and LyP1 fusing eGFP recombination protein by expressing system in E coli. respectively, and then put the recombination protein into the medium of serum starving SMMC-7721 liver cancer cell line, after treating 3 hours, to detect the binding capacity by Fluorescence microscopy. Results: when eGFP at the Carboxyl terminal of targeting peptides, the recombination protein could bind to the cell; But when eGFP at the Nitro terminal, the recombination protein loss the binding capacity. On the basis of these researches, the other 3 targeting peptides were detected. Conclusion: These results indicate that an inappropriate fusion strategy would lead to decreased or even totally loss of function of targeting peptides. Thus, it should be cautious when used EGFP as a tracer to study the targeting activities of peptides.

Key wordsTargeting peptide      GE11      LyP1      RGD4c     
Received: 15 February 2012      Published: 25 June 2012
ZTFLH:  Q819  
Cite this article:

WANG Hai, SHI Bi-zhi, YANG Sheng-li, LI Zong-hai, LUO Xiao-ying. Location of EGFP Tag Affects the Binding Activity of Peptide Fusions. China Biotechnology, 2012, 32(6): 74-78.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2012/V32/I6/74

[1] Aima O H, Liu R, Sutcliffe J L, et al. Combinatorial chemistry to cancer-targeting peptides. Mol Pharmaceut, 2007,4:631-651.
[2] Arap W A, Pasqualini R, Ruoslanti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science, 1998,279:377-380.
[3] Yao V J, Pzawa M G, Varner A S, et al. Antiangiogenic therapy decreases integrin expression in normalized tumor blood vessels. Cancer Res, 2006,66:2639-2649.
[4] Du B, Qin M, Zhou Z, et al. In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library. Biochem Bioph Res Co, 2006,342:956-962.
[5] Oyama T, Sykes K F, Samli K N, et al. Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents. Cancer Lett, 2003,202:219-230.
[6] Hong F D, Clayman G L. Isolation of a peptide for targeted drug delivery into human head and neck solid tumors. Cancer Res, 2000,60:6551-6556.
[7] Laakkonen P, Porkka K, Hoffman J A, et al. A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat Med, 2002,8:751-755.
[8] Fukuda M N, Ohyama C, Lowitz K, et al. A peptide mimic of e-selectin ligand inhibits sialyl lewis x-dependent lung colonization of tumor cells. Cancer Res, 2000,60:450-456.
[9] Wang X F, Birringer M, Dong L F, et al. A peptide conjugate of vitamin E succinate targets breast cancer cells with high erbb2 expression. Cancer Res, 2007,67:3337-3334.
[10] Shadidi M, Sioud M. Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells. FASEB J, 2002,17:256-258.
[11] Medina-Kauwe L K, Leung V, Wu L, et al. Assessing the binding and endocytosis activity of cellular receptors using GFP-ligand fusions. BioTechniques, 2000,29:602-609.
[12] Cormack B P, Valdivia R H, Falkow S. FACS-optimized mutants of the green fluorescent protein (GFP). Gene, 1995,173: 33-38.
[13] Heim R, Cubitt A B, Tsien R Y. Improved green fluorescence. Nature, 1995,373: 663-664.
[14] Zhang G, Gurtu V, Kain S R. An enhanced green fluorescent protein allows sensitive detection of gene transfer in mammalian cells. Biochem Bioph Res Co, 1996, 227: 707-711.
[15] Jiang H, Zhang J, Shi B Z, et al. Application of EGFP-EGF fusions to explore mechanism of endocytosis of epidermal growth factor. Acta Pharmacol Sin, 2007, 28:111-117.
[16] Li Z H, Zhao R, Wu X H, et al. Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics. FASEB J, 2005,19:1978-1985.
[1] . [J]. China Biotechnology, 2021, 41(12): 1-3.
[2] WU Han-rong,WANG Ying,HUANG Ying-ming,LI Dong-xue,LI Zhi-fei,FANG Zi-han,FAN Lin. Promote the Innovation and Transformation of Biotechnology by Base Platform[J]. China Biotechnology, 2021, 41(12): 141-147.
[3] YIN Ze-chao,WANG Xiao-fang,LONG Yan,DONG Zhen-ying,WAN Xiang-yuan. Advances on Genetic Research and Mechanism Analysis on Maize Resistance to Ear Rot[J]. China Biotechnology, 2021, 41(12): 103-115.
[4] LENG Yan,SUN Kang-tai,LIU Qian-qian,PU A-qing,LI Xiang,WAN Xiang-yuan,WEI Xun. Trends of Global Gene-edited Crops Supervision[J]. China Biotechnology, 2021, 41(12): 24-29.
[5] HE Wei,ZHU Lei,LIU Xin-ze,AN Xue-li,WAN Xiang-yuan. Research Progress on Maize Genetic Transformation and Commercial Development of Transgenic Maize[J]. China Biotechnology, 2021, 41(12): 13-23.
[6] YANG Meng-bing,JIANG Yi-lin,ZHU Lei,AN Xue-li,WAN Xiang-yuan. CRISPR/Cas Plant Genome Editing Systems and Their Applications in Maize[J]. China Biotechnology, 2021, 41(12): 4-12.
[7] YIN Fang-bing,WANG Cheng,LONG Yan,DONG Zhen-ying,WAN Xiang-yuan. Progress on Dissecting Genetic Architecture and Formation Mechanism of Maize Ear Traits[J]. China Biotechnology, 2021, 41(12): 30-46.
[8] QIN Wen-xuan,LIU Xin,LONG Yan,DONG Zhen-ying,WAN Xiang-yuan. Progress on Genetic Analysis and Molecular Dissection on Maize Leaf Angle Traits[J]. China Biotechnology, 2021, 41(12): 74-87.
[9] WANG Rui-pu,DONG Zhen-ying,GAO Yue-xin,LONG Yan,WAN Xiang-yuan. Research Progress on Genetic Structure and Regulation Mechanism on Starch Content in Maize Kernel[J]. China Biotechnology, 2021, 41(12): 47-60.
[10] MA Ya-jie,GAO Yue-xin,LI Yi-ping,LONG Yan,DONG Zhen-ying,WAN Xiang-yuan. Progress on Genetic Analysis and Molecular Dissection on Maize Plant Height and Ear Height[J]. China Biotechnology, 2021, 41(12): 61-73.
[11] WANG Yan-bo,WEI Jia,LONG Yan,DONG Zhen-ying,WAN Xiang-yuan. Research Advances on Genetic Structure and Molecular Mechanism Underlying the Formation of Tassel Traits in Maize[J]. China Biotechnology, 2021, 41(12): 88-102.
[12] MAO Kai-yun,LI Rong,LI Dan-dan,ZHAO Ruo-chun,FAN Yue-lei,JIANG Hong-bo. Analysis of the Current Status of Global Bispecific Antibody Development[J]. China Biotechnology, 2021, 41(11): 110-118.
[13] WU Han-rong,WANG Ying,YANG Li,GE Yao,FAN Ling. Current Situation and Development Suggestions of China’s Biotechnology Base Platform[J]. China Biotechnology, 2021, 41(11): 119-123.
[14] LIU Tian-yi,FENG Hui,SALSABEEL Yousuf,XIE Ling-li,MIAO Xiang-yang. Research Progress of lncRNA in Animal Fat Deposition[J]. China Biotechnology, 2021, 41(11): 82-88.
[15] XUE Zhi-yong,DAI Hong-sheng,ZHANG Xian-yuan,SUN Yan-ying,HUANG Zhi-wei. Effects of Vitreoscilla Hemoglobin Gene on Growth and Intracellular Oxidation State of Saccharomyces cerevisiae[J]. China Biotechnology, 2021, 41(11): 32-39.